-+ 0.00%
-+ 0.00%
-+ 0.00%

Kyverna Therapeutics Q1 EPS $(1.03) Misses $(0.99) Estimate

Benzinga·05/13/2025 20:14:27
Listen to the news
Kyverna Therapeutics (NASDAQ:KYTX) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(0.99) by 4.04 percent. This is a 8.04 percent increase over losses of $(1.12) per share from the same period last year.